ProMIS Neurosciences Inc - Company Profile
Powered by 
All the data and insights you need on ProMIS Neurosciences Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date ProMIS Neurosciences Inc Strategy Report
- Understand ProMIS Neurosciences Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on ProMIS Neurosciences Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US11779629B2 | Grant | Compositions comprising cyclic peptides derived from an a-beta peptide | A61K2039/505; A61K2039/55505; A61K2039/6081; A61K2300/00; A61K38/00; A61K38/05; A61K38/07; A61K38/08; A61K38/12; A61K39/00; A61K39/385; A61K39/39; A61K39/395; A61K39/39533; A61K39/3955; A61K45/05; A61K45/06; A61K47/643; A61K47/646; A61K47/6803; A61K47/6921; A61K49/1818; A61K49/1866; A61K51/088; A61K51/10; A61K51/1018; A61L27/227; A61L27/34; A61L29/085; A61L29/16; A61L31/10; A61L31/16; A61P25/28; C07K14/435; C07K14/4711; C07K16/18; C07K2317/20; C07K2317/24; C07K2317/30; C07K2317/33; C07K2317/34; C07K2317/524; C07K2317/526; C07K2317/54; C07K2317/55; C07K2317/56; C07K2317/565; C07K2317/569; C07K2317/624; C07K2317/626; C07K2317/70; C07K2317/76; C07K2317/92; C07K2317/94; C07K2319/00; C07K5/0808; C07K5/081; C07K5/0812; C07K5/0815; C07K5/0819; C07K5/0821; C07K5/101; C07K5/1021; C07K5/1024; C07K7/06; C07K7/08; C07K7/64; C12N5/10; C12N5/16; G01N2333/4709; G01N2800/28; G01N2800/2821; G01N2800/387; G01N33/5058; G01N33/6896 | October 10, 2023 |
| CN116333108A | Application | Antibodies to amyloid beta | A61K39/0007; A61K47/6843; G01N33/60; G01N2333/4709; G01N2800/2821; A61K49/0008; C12N5/16; A61P25/28; A61K38/1716; G01N33/6896; A61K2039/505; A61K51/1018; C07K16/18; C07K2317/34; C07K2317/565; C07K2317/76; C07K2317/55; C07K2317/24; G01N33/6854; C07K2317/33; C07K2317/92 | June 27, 2023 |
| JP2023086132A | Application | Antibodies to amyloid beta | A61K2039/505; A61P25/28; C07K16/18; G01N33/6896; C07K2317/24; G01N2333/4709; C07K2317/92 | June 21, 2023 |
| EP3976793A4 | Search Report | Konformationsspezifische epitope in tau, antikörper dagegen und verfahren im zusammenhang damit | A61K2039/55505; A61K39/0005; A61K39/385; A61K39/39; A61K47/643; A61K47/646; A61P25/28; C07K14/4711; C07K16/18; C07K2317/32; C07K2317/34; C07K2317/56; C07K2317/565; C07K2317/76; C07K5/0827; C07K5/1008; C07K5/101; C07K5/1019; C07K5/12; C07K7/06; C12N5/163; G01N2333/4709; G01N2800/2821; G01N33/6896 | June 21, 2023 |
| US20230141177A1 | Application | Antibodies to misfolded amyloid beta | A61K2039/505; A61K47/6843; A61P25/28; C07K16/18; C07K2317/24; C07K2317/32; C07K2317/33; C07K2317/34; C07K2317/522; C07K2317/524; C07K2317/55; C07K2317/565; C07K2317/622; C07K2317/92; G01N2333/4709; G01N33/532; G01N33/6896 | May 11, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer